CaaMTech is a drug discovery company with a focus on engineering psychedelic drugs, including psilocybin.
We pitched the CaaMTech team some questions about their progress and future plans, as well as some broader questions about the psychedelic medicine space…
US20190142851A1 | Compositions comprising a psilocybin derivative and a cannabinoid
Priority Date: 2017-11-16 | Pending in US
General Subject Matter: Purified psilocybin derivatives combined with a cannabinoid
US20180221396A1 | Compositions and methods comprising a psilocybin derivative
Priority Date: 2017-02-09 | Status: Pending in US
General Subject Matter: Purified psilocybin derivatives, some together with cannabinoids and terpenes, for treatment of psychological disorders